Intraosseous regional prophylactic antibiotics decrease the risk of prosthetic joint infection in primary TKA: a multicenter study

Parkinson, Ben, McEwen, Peter, Wilkinson, Matthew, Hazratwala, Kaushik, Hellman, Jorgen, Kan, Heng, McLean, Andrew, Panwar, Yash, Doma, Kenji, and Grant, Andrea (2021) Intraosseous regional prophylactic antibiotics decrease the risk of prosthetic joint infection in primary TKA: a multicenter study. Clinical orthopaedics and related research, 479 (11). pp. 2504-2512.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website:


Background: Recent studies have demonstrated that the administration of regional prophylactic antibiotics by intraosseous (IO) injection achieves tissue concentrations around the knee that are 10- to 15-fold higher than intravenous (IV) delivery of prophylactic antibiotics. It is currently unknown whether the use of regional prophylactic antibiotics for primary TKA would result in a lower risk of prosthetic joint infection (PJI).

Questions/purposes: (1) Is IO injection of prophylactic antibiotics associated with a decreased risk of early (< 12 months) deep PJI compared with traditional IV prophylactic antibiotics? (2) What other patient factors are associated with an increased risk of early PJI after TKA, and do regional prophylactic antibiotics influence these risk factors? (3) Can IO antibiotics be administered to all patients, and what complications occurred from the delivery of IO prophylactic antibiotics?

Methods: A retrospective comparative study of all primary TKAs (1909 TKAs) over a 5-year period (January 2013 to December 2017) was performed to determine the risk of early PJI. Three primary TKAs did not meet the study inclusion criteria and were excluded from the study, leaving a total of 1906 TKAs (725 IO, 1181 IV) for analysis at a minimum of 12 months after index procedure. Both cohorts exhibited similar ages, BMI, and American Society of Anesthesiologists (ASA) grades; however, a greater proportion of patients in the IO cohort were smokers (p = 0.01), while a greater proportion of patients were diabetic in the IV cohort (p = 0.006). The PJI risk between IO and IV delivery techniques was compared while adjusting for patient demographics and medical comorbidities. Complications related to IO delivery—inability to administer via IO technique, compartment syndrome, fat embolism, and red man syndrome with vancomycin use—were recorded.

Results: The delivery of regional prophylactic antibiotics by the IO technique resulted in a lower PJI risk than IV prophylactic antibiotics (0.1% [1 of 725] compared with 1.4% [16 of 1181]; relative risk 0.10 [95% CI 0.01 to 0.77]; p = 0.03). BMI (β = -0.17; standard error = 0.08; p = 0.02), diabetes (β = -1.80; standard error = 0.75; p = 0.02), and renal failure (β = -2.37; standard error = 0.84; p = 0.01) were factors associated with of PJI, while smoking, sex, and ASA score were not contributing factors (p > 0.05). Although BMI, diabetes, and renal failure were identified as infection risk factors, the use of IO antibiotics in these patients did not result in a lower PJI risk compared with IV antibiotics (p > 0.05). IO antibiotics were able to be successfully administered to all patients in this cohort, and there were no complications related to the delivery of IO antibiotics.

Conclusion: Surgeons should consider administering regional prophylactic antibiotics in primary TKA to reduce the risk of early PJI. Future randomized prospective clinical trials are needed to validate the efficacy of regional prophylactic antibiotics in reducing the PJI risk in primary TKA.

Item ID: 71551
Item Type: Article (Research - C1)
ISSN: 1528-1132
Keywords: Antibiotic Prophylaxis; Methods; Arthroplasty, Replacement, Knee; Adverse Effects; Antibiotics; Administration and Dosage; Prosthesis-Related Infections; Prevention and Control; Arthritis, Infectious; Prevention and Control; Prosthesis-Related Infections; Etiology
Copyright Information: © 2021 by the Association of Bone and Joint Surgeons.
Date Deposited: 07 Feb 2022 23:51
FoR Codes: 32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320216 Orthopaedics @ 100%
SEO Codes: 20 HEALTH > 2001 Clinical health > 200104 Prevention of human diseases and conditions @ 100%
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page